[ RECIPIENT ENTITY RECORD ]

Roche Immunology

VERIFIED NODE ID: 002090 · roche-immunology
R TARGET NODE — CAPITAL RECIPIENT
Roche Immunology
SPV Switzerland
Recipient Type
SPV
Primary Jurisdiction
Switzerland
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Roche Immunology
Entity Type SPV
Jurisdiction Switzerland
Recipient Intelligence Summary

Roche Immunology represents the world-leading biotechnology research and development division focused on treating chronic inflammatory diseases. Based in Switzerland, the project leads in oncology and pharmaceutical innovation. It was a significant recipient of institutional healthcare capital through strategic biotech acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $7.1B